Share this

Article Facebook

Twitter

Email You are free to share this article under the Attribution 4.0 International license. University University of Southampton

Inspired by amphibians like salamanders that can regrow lost limbs, scientists are working to develop a new type of drug that may help bones heal faster and better.

Using bone samples from people undergoing hip replacement surgery, the research shows that the new drug—a protein that activates a molecular pathway called the “Wnt” pathway—causes stem cells found within bones to divide and to turn into more bone cells.

The Wnt pathway is found throughout the animal kingdom—from sponges to humans—and plays a fundamental role in animal development and disease. It is involved in controlling the growth of stem cells, called “master cells” that help restore tissues after injury. One example of this is in amphibians like salamanders. If these animals lose a leg, they can just regrow a new one.

“Bone fractures are a big problem in society, especially in older people,” says Nick Evans, associate professor in bioengineering at the University of Southampton and lead author of the study in the journal Stem Cells.

“It is getting worse as more people get older and their risk of fracture increases. Most fractures heal completely by themselves, but a surprising number, around 10 percent, take over six months to heal, or never heal at all. In the worst cases this can lead to several surgical operations, or even amputation.

“Through our research, we are trying to find ways to chemically stimulate Wnt signaling using drugs. To achieve this, we selectively deliver proteins and other molecules that change Wnt signalling specifically to stem cells, particularly in the bone. This may help us find cures for many diseases, including bone disease, and speed up bone healing after fracture.”

However, if the Wnt pathway was switched on too long, the regenerative effect was lost or, even reversed, Evans says.

“This is why it is particularly important to develop technologies for timed and targeted delivery, which is what we have done in this research.”

Source: University of Southampton